unknown
Stage
1
Investors
About
CORXEL Pharmaceuticals is a biopharmaceutical company developing innovative therapies for cardiometabolic and cardiovascular diseases, with operations in the US and China focused on treating conditions like hypertrophic cardiomyopathy and heart failure.
Explore CORXEL Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.